comparemela.com

Latest Breaking News On - Dina burkitbayeva - Page 1 : comparemela.com

Freedom Biosciences Announces FDA Approval of IND Application for FREE001 in Patients with Treatment-Resistant Depression

/PRNewswire/ Freedom Biosciences, Inc. ("Freedom Bio" or the "Company"), a clinical-stage biotechnology platform focused on developing next-generation.

United statesJannsen spravatoDina burkitbayevaDavid houghSmith carlsJohn krystalRob bermanIus dept of healthBiohaven pharmaceuticalsNational survey on drugMental health services administrationFreedom biosciences incMental health indicatorsDrug administrationHuman servicesNational burden of treatment

Perspectives From The Largest Psychedelic Conference In History

Psychedelic-assisted therapy is full of promise, and peril. Here are several key themes and perspectives from the Psychedelic Science 2023 meeting.

United statesRick doblinImran khanRolandr griffithsDina burkitbayevaRachel yehudaMichael pollanJeeshan chowdhuryJohns hopkinsDavidb yadenJoshua gordonManish agrawalMarian goodellLucia huangMattheww johnsonNational institutes for mental health

Meet A VC On A Mission To Support Women In Longevity

The field of longevity biotechnology is rapidly evolving. Meet the venture capitalist dedicated to supporting and promoting female founders.

San franciscoUnited statesStanford universityNew yorkJohn krystalMorten scheibye knudsenTony robbinsMridu sinhaDaniela bakulaAnastasia georgievskayaGarri zmudzeAgnese veckalneDenitsa milanovaOriana papin zoghbiDina burkitbayevaAndrea olsen

LongeVC Invests in Freedom Biosciences

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Dina burkitbayevaJohn krystalYale universityFreedom biosciencesPsymed ventures

LongeVC Joins Freedom Biosciences Funding Round For Psychedelic-Powered Mental Health Care

Company pioneering the use of ketamine and other compounds in next-generation treatmentsSAN FRANCISCO (BUSINESS WIRE) #MentalHealth Biotech fund LongeVC has invested in psychedelics startup Freedom Biosciences. Founded by Yale University professor Dr. John Krystal and PsyMed Ventures co-founder Dina Burkitbayeva,.

Dina burkitbayevaJanssen spravato esketamineHannah fosterHunter bouchardMorgan springerJohn krystalGarri zmudzeYale universityDepartment of psychiatry at yale universityPsymed venturesFreedom biosciencesSpravato esketamineVillage global

vimarsana © 2020. All Rights Reserved.